Researcher profile

Petar Jolakoski

Petar Jolakoski contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Correlates of the country differences in the infection and mortality rates during the first wave of the COVID-19 pandemic: Evidence from Bayesian model averaging

In the initial wave of the COVID-19 pandemic we observed great discrepancies in both infection and mortality rates between countries. Besides the biological and epidemiological factors, a multitude of social and economic criteria also influence the extent to which these discrepancies appear. Consequently, there is an active debate regarding the critical socio-economic and health factors that correlate with the infection and mortality rates outcome of the pandemic. Here, we leverage Bayesian model averaging techniques and country level data to investigate the potential of 28 variables, describing a diverse set of health and socio-economic characteristics, in being correlates of the final number of infections and deaths during the first wave of the coronavirus pandemic. We show that only few variables are able to robustly correlate with these outcomes. To understand the relationship between the potential correlates in explaining the infection and death rates, we create a Jointness Space. Using this space, we conclude that the extent to which each variable is able to provide a credible explanation for the COVID-19 infections/mortality outcome varies between countries because of their heterogeneous features.

preprint2021arXiv

Income inequality and mobility in geometric Brownian motion with stochastic resetting: theoretical results and empirical evidence of non-ergodicity

We explore the role of non-ergodicity in the relationship between income inequality, the extent of concentration in the income distribution, and mobility, the feasibility of an individual to change their position in the income distribution. For this purpose, we explore the properties of an established model for income growth that includes "resetting" as a stabilising force which ensures stationary dynamics. We find that the dynamics of inequality is regime-dependent and may range from a strictly non-ergodic state where this phenomenon has an increasing trend, up to a stable regime where inequality is steady and the system efficiently mimics ergodic behaviour. Mobility measures, conversely, are always stable over time, but the stationary value is dependent on the regime, suggesting that economies become less mobile in non-ergodic regimes. By fitting the model to empirical data for the dynamics of income share of the top earners in the United States, we provide evidence that the income dynamics in this country is consistently in a regime in which non-ergodicity characterises inequality and immobility dynamics. Our results can serve as a simple rationale for the observed real world income dynamics and as such aid in addressing non-ergodicity in various empirical settings across the globe.

preprint2021arXiv

The impact of state capacity on the cross-country variations in COVID-19 vaccination rates

The initial period of vaccination shows strong heterogeneity between countries' vaccinations rollout, both in the terms of the start of the vaccination process and in the dynamics of the number of people that are vaccinated. A predominant thesis in the ongoing debate on the drivers of this observed heterogeneity is that a key determinant of the swift and extensive vaccine rollout is state capacity. Here, we utilize two measures that quantify different aspects of the state capacity: i) the external capacity (measured through the soft power and the economic power of the country) and ii) the internal capacity (measured via the country's government effectiveness) and investigate their relationship with the coronavirus vaccination outcome in the initial period (up to 30th January 2021). By using data on 189 countries and a two-step Heckman approach, we find that the economic power of the country and its soft power are robust determinants of whether a country has started with the vaccination process. In addition, the government effectiveness is a key factor that determines vaccine roll-out. Altogether, our findings are in line with the hypothesis that state capacity determines the observed heterogeneity between countries in the initial period of COVID-19 vaccines rollout.